Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farrell O Mendelsohn

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 27, 2014
Does complete renal denervation translate into superior clinical outcomes? Lessons learned from denervation of accessory renal arteriesFarrell O Mendelsohn
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 22, 2020
Expanding the stroke team to include interventional cardiologyFarrell O Mendelsohn, David R Holmes, L Nelson Hopkins
Clinical Anatomy (New York, N.Y.)|October 7, 2011
Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic studyDaniel S Atherton, Nicholas L Deep, Farrell O Mendelsohn
The Journal of Invasive Cardiology|January 8, 2009
Hyperperfusion syndrome following carotid artery stenting: the largest single-operator series to dateHutton P Brantley, Jennifer L Kiessling, Hugh B Milteer, et al.
Journal of Vascular Surgery|December 15, 2010
Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trialRichard J Powell, Phillip Goodney, Farrell O Mendelsohn, et al.
Circulation Research|November 5, 2011
Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical studyMarc S Penn, Stephen Ellis, Sanjay Gandhi, et al.
Circulation Research|February 23, 2013
An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failureMarc S Penn, Farrell O Mendelsohn, Gary L Schaer, et al.
Human Gene Therapy|June 24, 2004
Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial diseaseSanjay Rajagopalan, Jeffrey W Olin, Stuart Young, et al.
Journal of Hypertension|May 31, 2014
Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine modelMeital Cohen-Mazor, Prabodh Mathur, James R L Stanley, et al.
Circulation|September 25, 2003
Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudicationSanjay Rajagopalan, Emile R Mohler, Robert J Lederman, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 27, 2014
Does complete renal denervation translate into superior clinical outcomes? Lessons learned from denervation of accessory renal arteriesFarrell O Mendelsohn
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 22, 2020
Expanding the stroke team to include interventional cardiologyFarrell O Mendelsohn, David R Holmes, L Nelson Hopkins
Clinical Anatomy (New York, N.Y.)|October 7, 2011
Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic studyDaniel S Atherton, Nicholas L Deep, Farrell O Mendelsohn
The Journal of Invasive Cardiology|January 8, 2009
Hyperperfusion syndrome following carotid artery stenting: the largest single-operator series to dateHutton P Brantley, Jennifer L Kiessling, Hugh B Milteer, et al.
Journal of Vascular Surgery|December 15, 2010
Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trialRichard J Powell, Phillip Goodney, Farrell O Mendelsohn, et al.
Circulation Research|November 5, 2011
Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical studyMarc S Penn, Stephen Ellis, Sanjay Gandhi, et al.
Circulation Research|February 23, 2013
An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failureMarc S Penn, Farrell O Mendelsohn, Gary L Schaer, et al.
Human Gene Therapy|June 24, 2004
Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial diseaseSanjay Rajagopalan, Jeffrey W Olin, Stuart Young, et al.
Journal of Hypertension|May 31, 2014
Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine modelMeital Cohen-Mazor, Prabodh Mathur, James R L Stanley, et al.
Circulation|September 25, 2003
Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudicationSanjay Rajagopalan, Emile R Mohler, Robert J Lederman, et al.
Pageof 2